The Ratio of Monomeric to Aggregated Forms of Aβ40 and Aβ42 Is an Important Determinant of Amyloid-β Aggregation, Fibrillogenesis, and Toxicity
Open Access
- 1 October 2008
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (42), 28176-28189
- https://doi.org/10.1074/jbc.m803159200
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Aβ40 Protects Non-toxic Aβ42 Monomer from AggregationJournal of Molecular Biology, 2007
- Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho‐Tau in patients with low‐ and high‐CSF Aβ40 loadJournal of Neurochemistry, 2006
- CSF diagnosis of Alzheimer’s disease and dementia with Lewy bodiesJournal of Neural Transmission, 2006
- Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragmentNeurobiology of Disease, 2005
- Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer AdditionPLoS Biology, 2004
- Mixtures of Wild-type and a Pathogenic (E22G) Form of Aβ40 in Vitro Accumulate Protofibrils, Including Amyloid PoresJournal of Molecular Biology, 2003
- α-Synuclein, Especially the Parkinson's Disease-associated Mutants, Forms Pore-like Annular and Tubular ProtofibrilsJournal of Molecular Biology, 2002
- How to measure and predict the molar absorption coefficient of a proteinProtein Science, 1995
- Biochemical Evidence for the Long-Tail Form (Aβ1-42/43) of Amyloid β Protein as a Seed Molecule in Cerebral Deposits of Alzheimer′s DiseaseBiochemical and Biophysical Research Communications, 1994
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991